Referral pathways for NAFLD fibrosis in primary care – No longer a ‘needle in a haystack’

Non-alcoholic fatty liver disease (NAFLD) is the commonest form of liver disease in primary care, with rates up to 25%.1 This figure, however, encompasses the whole spectrum of NAFLD from simple steatosis, non-alcoholic steatohepatitis (NASH) through to advanced fibrosis/cirrhosis. Due to the strong association with liver-related morbidity and premature death,2,3 fibrosis has become the main focus in secondary care for risk stratification, targeted lifestyle and metabolic risk management and drug trial recruitment.

Source: Journal of Hepatology - June 18, 2019 Category: Gastroenterology Authors: Matthew J. Armstrong, Giulio Marchesini Tags: Editorial Source Type: research